Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Dettagli Bibliografici
Autori principali:	Leask, A, Xu, S, Renzoni, E, Bou-Gharios, G, du Bois, R, Abraham, D, Black, C
Natura:	Conference item
Pubblicazione:	2005

Documenti analoghi

Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
di: Shiwen, X, et al.
Pubblicazione: (2006)

Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
di: S. Soldano, et al.
Pubblicazione: (2011-01-01)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
di: Alix Naert, et al.
Pubblicazione: (2013-01-01)

CTGF overexpressing mice: a model for human scleroderma
di: Sonnylal, S, et al.
Pubblicazione: (2006)

Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
di: Emma Di Poi, et al.
Pubblicazione: (2023-11-01)

Scleroderma with Nodular Scleroderma
di: Chutika Srisuttiyakorn, et al.
Pubblicazione: (2016-11-01)

Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.
di: Shi-Wen, X, et al.
Pubblicazione: (2007)

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.
di: Shi-Wen, X, et al.
Pubblicazione: (2004)

Scleroderma and scleroderma-like syndromes
di: Katarzyna Romanowska-Próchnicka, et al.
Pubblicazione: (2024-06-01)

Corrigendum: Scleroderma and Scleroderma-like syndromes
di: Katarzyna Romanowska-Próchnicka, et al.
Pubblicazione: (2024-07-01)

Paraneoplastic scleroderma or neoplasia secondary to scleroderma
di: Alexandru Arvunescu, et al.
Pubblicazione: (2019-12-01)

Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
di: Richard A Steinman, et al.
Pubblicazione: (2012-01-01)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
di: Michael Macklin, et al.
Pubblicazione: (2023-02-01)

Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
di: Bahja Ahmed Abdi, et al.
Pubblicazione: (2017-06-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
di: N. A. Shostak, et al.
Pubblicazione: (2020-05-01)

Keloids in scleroderma-keloidal scleroderma: A unique entity
di: Sumit Sen, et al.
Pubblicazione: (2013-01-01)

The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo
di: Stephanie Arndt, et al.
Pubblicazione: (2021-10-01)

Intramuscular Polydeoxyribonucleotides in Fibrotic and Atrophic Localized Scleroderma: An Explorative Prospective Cohort Study
di: Maurizio Romagnuolo, et al.
Pubblicazione: (2023-04-01)

Genetics of scleroderma: implications for personalized medicine?
di: Assassi Shervin, et al.
Pubblicazione: (2013-01-01)

Mimics of scleroderma
di: Kaveri K Nalianda, et al.
Pubblicazione: (2017-01-01)

The pathogenesis of scleroderma
di: Latika Gupta, et al.
Pubblicazione: (2017-01-01)

Rac inhibition reverses the phenotype of fibrotic fibroblasts.
di: Shi-wen Xu, et al.
Pubblicazione: (2009-10-01)

Response of human lung fibroblast cells to stimulation by endothelin-1: Involvement of ras/MEK/ERK and PI3 kinase
di: Shiwen, X, et al.
Pubblicazione: (2003)

Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
di: Shi-wen, X, et al.
Pubblicazione: (2007)

OVERDENTURE IN SCLERODERMA'S PATIENT
di: , Elin Hertiana
Pubblicazione: (2012)

GI Manifestation in Scleroderma
di: Chingching Foocharoen
Pubblicazione: (2024-01-01)

Phaeochromocytoma Mimicking Scleroderma
di: Joan Joo-Ching Khoo, et al.
Pubblicazione: (2011-01-01)

Treatment for systemic scleroderma
di: Rezvaya Tairovich Alekperov, et al.
Pubblicazione: (2011-09-01)

Scleroderma and related disorders
di: Anupam Wakhlu, et al.
Pubblicazione: (2017-01-01)

Thelytoky in Scleroderma Immigrans
di: Clyde E. Keeler
Pubblicazione: (1929-01-01)

Human otopathology in scleroderma
di: Melissa Castillo‐Bustamante, et al.
Pubblicazione: (2023-12-01)

Finger Printlessness in Scleroderma
di: Milad HOSSEINIALHASHEMI, et al.
Pubblicazione: (2016-08-01)

Scleroderma lung disease
di: Joshua J. Solomon, et al.
Pubblicazione: (2013-03-01)

Scleroderma renal crisis
di: Gioacchino Li Cavoli, et al.
Pubblicazione: (2018-01-01)

Purtscher’s retinopathy in scleroderma
di: Alzahrani, Mazen, et al.
Pubblicazione: (2019-03-01)

Treatment for systemic scleroderma
di: Rezvaya Tairovich Alekperov, et al.
Pubblicazione: (2011-09-01)

Localized scleroderma in children
di: Katarzyna A. Wolska-Gawron, et al.
Pubblicazione: (2020-06-01)

Scleroderma-related choroiditis
di: Parthopratim Dutta Majumder, et al.
Pubblicazione: (2018-01-01)

Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin
di: Marvin L. Frommer, et al.
Pubblicazione: (2023-07-01)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
di: Magdalena Marek, et al.
Pubblicazione: (2016-06-01)